Karyopharm Therapeut
(KPTI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 84,908 | 136,252 | 72,431 | 83,394 | 154,270 |
| Marketable Securities | 176,322 | 142,779 | 77,030 | 88,598 | 52,055 |
| Receivables | 35,200 | 47,086 | 27,446 | 23,479 | 24,992 |
| Inventories | 3,827 | 4,224 | 4,249 | 3,470 | 3,874 |
| Other current assets | 0 | 0 | 31,468 | 32,078 | 29,135 |
| TOTAL | $318,541 | $350,162 | $222,677 | $242,447 | $276,533 |
| Non-Current Assets | |||||
| PPE Net | 849 | 1,139 | 1,252 | 1,395 | 1,544 |
| Other Non-Current Assets | 6,410 | 6,871 | 7,307 | 12,636 | 15,956 |
| TOTAL | $7,259 | $8,010 | $8,559 | $14,031 | $17,500 |
| Total Assets | $325,800 | $358,172 | $231,236 | $256,478 | $294,033 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,045 | 2,773 | 813 | 1,694 | 3,440 |
| Accrued Expenses | 47,032 | 58,415 | 55,716 | 56,367 | 58,371 |
| Other current liabilities | 2,501 | 1,848 | 2,462 | 1,865 | 2,063 |
| TOTAL | $61,555 | $65,908 | $61,761 | $62,541 | $66,337 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 309,419 | 308,920 | 309,755 | 310,275 | 310,775 |
| TOTAL | $309,419 | $308,920 | $309,755 | $310,275 | $310,775 |
| Total Liabilities | $370,974 | $374,828 | $371,516 | $372,816 | $377,112 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,604 | 7,560 | 5,413 | 5,323 | 5,297 |
| Common Shares | 12 | 12 | 8 | 8 | 8 |
| Retained earnings | -1,378,065 | -1,343,939 | -1,305,433 | -1,269,109 | -1,220,047 |
| Other shareholders' equity | -419 | -638 | -752 | -538 | 87 |
| TOTAL | $-45,174 | $-16,656 | $-140,280 | $-116,338 | $-83,079 |
| Total Liabilities And Equity | $325,800 | $358,172 | $231,236 | $256,478 | $294,033 |